Back to Journals » OncoTargets and Therapy » Volume 12
Review
First-line treatment of women with advanced ovarian cancer: focus on bevacizumab
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
28,953 | Dovepress* | 11,381+ | 1,341 | 12,722 | |
PubMed Central* | 17,572 | 2,220 | 19,792 | ||
Totals | 28,953 | 3,561 | 32,514 | ||
*Since 8 February 2019 |
View citations on PubMed Central and Google Scholar